It is true that we do not at present recommend the Buteyko technique, just as we never recommend any new treatment or technique without rigorous clinical trials published, after peer review, in a reputable medical journal.
The double-blind clinical trial referred to in your article has not been published in this way. Its results are interim and therefore not peer- reviewed. They are drawn from one trial of 43 people who self-reported the extent of their symptoms, thus increasing the likelihood of a placebo effect.
As your article points out, even the author of the interim study is sceptical about the benefits of the technique.
The National Asthma Campaign cannot recommend that the 3 million people in the United Kingdom who have asthma entirely abandon their orthodox treatment and rely on this technique on the basis of a study of just 43 people.
National Asthma Campaign
London N1Reuse content